AMICUS THERAPEUTICS, INC.
Profile
Company Names
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS INC
Addresses
47 HULFISH STREET, PRINCETON, NJ 08542
3675 MARKET STREET, PHILADELPHIA, PA 19104
1 CEDAR BROOK DRIVE, CRANBURY, NJ 08512
6 CEDAR BROOK DRIVE, CRANBURY, NJ 08512
Phone Numbers
609-662-2000
(215) 921-7600
(609) 662-2000
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$314,489,428.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2023-10-05
$29,999,985.00
$29,999,985.00
$0.00
Equity
6
2021-09-29
$199,916,500.00
$199,916,500.00
$0.00
Equity
5
2016-07-05
$4,706,000.00
$4,706,000.00
$0.00
Equity
4
2013-11-20
$15,000,000.00
$15,000,000.00
$0.00
Equity
3
2013-11-19
$15,000,000.00
$15,000,000.00
$0.00
Equity
2
2012-07-17
$18,582,360.00
$18,582,360.00
$0.00
Equity
1
2010-10-28
$31,284,583.00
$31,284,583.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SOL
BARER
DIRECTOR
SOL
J.
BARER
DIRECTOR
JAMES
BARRETT
DIRECTOR
PREDICTIVE BIOSCIENCES, INC
| CARDIOXYL PHARMACEUTICALS INC
| PHASEBIO PHARMACEUTICALS INC
| AMICUS THERAPEUTICS INC
| HOMETOWN FINANCIAL GROUP INC
| BLEND BIOSCIENCES, INC.
| BLEND THERAPEUTICS, INC.
| AGENEBIO, INC.
| ZP HOLDINGS INC
| LOXO ONCOLOGY, INC.
| NEXIMMUNE, INC.
| GALERA THERAPEUTICS, INC.
| TARVEDA THERAPEUTICS, INC.
| EDGE TOTAL INTELLIGENCE INC.
| ABSURD SNACKS - LIGHTHOUSE NETWORK VENTURES, LLC
BRADLEY
CAMPBELL
EXECUTIVE OFFICER, DIRECTOR
DAVID
CLARK
EXECUTIVE OFFICER
NORMOXYS INC
| GOODMAN FIELDER LTD /FI
| DOOR TO DOOR ORGANICS, INC.
| GROUP 47, INC.
| WIRELESS ADVANCED VEHICLE ELECTRIFICATION, INC.
| QIC BALLSTON COMMON RETAIL REIT INC.
| QIC WIREGRASS REIT INC.
| QIC BALLSTON COMMON OFFICE REIT INC.
| QIC BALLSTON COMMON RESIDENTIAL REIT INC.
| QIC RIDGE HILL REIT INC.
| WESTWOOD GLOBAL ENERGY LTD
| CATTLOG, INC.
| REVOLUTION POWER, INC.
| GLOWPOINT, INC.
| OBLONG, INC.
| BURIN GOLD CORP.
| AMICUS THERAPEUTICS, INC.
JOHN
CROWLEY
EXECUTIVE OFFICER, DIRECTOR
JOHN
F.
CROWLEY
EXECUTIVE OFFICER, DIRECTOR
ROBERT
ESSNER
DIRECTOR
DONALD
J.
HAYDEN, JR.
DIRECTOR
TED
W.
LOVE
DIRECTOR
JAMES
N.
TOPPER
DIRECTOR
ALNARA PHARMACEUTICALS INC
| ANAPTYSBIO INC
| AMICUS THERAPEUTICS INC
| FRAZIER HEALTHCARE VII-A, L.P.
| FRAZIER HEALTHCARE VII, L.P.
| FRAZIER LIFE SCIENCES VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
| APTINYX INC.
| FRAZIER LIFE SCIENCES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
| SERAXIS HOLDINGS, INC.
| FRAZIER LIFE SCIENCES XI, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
OVER $100,000,000
Equity
2021-09-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-07-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2013-11-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2013-11-19
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
Equity
2012-07-17
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2010-10-28
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
